Testosterone Gel Market Overview
Testosterone Gel is a type of Androgel used to treat low testosterone levels in males. Testosterone is a male sex hormone that aids in the development of secondary sex characteristics and male sex organs. Low testosterone levels in men have been linked to osteoporosis, erectile dysfunction, decreased sexual desire, fatigue, and the regression of secondary sexual features, among other things.
The growth of the testosterone gel market has been propelled by the rapid development of healthcare facilities and infrastructure. Furthermore, technological advancements, changing lifestyles, and hereditary diseases may result in lower testosterone levels, which is likely to drive market expansion. Other variables such as COPD, liver disease, pituitary gland disorders, diabetes, and others may affect testosterone levels, and underdevelopment of the testicles, which are responsible for testosterone production, are projected to boost the market growth.
On the negative side, the testosterone gel industry is projected to be hampered by a lack of awareness and few options with a variety of negative effects. Furthermore, over the forecast period, new product releases and FDA approval for new products by various manufacturers are projected to generate profitable prospects in the testosterone gel market.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, Application, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | AbbVie, Perrigo, Teva, Endo Pharmaceuticals, Lupin, Acerus Pharmaceuticals, Upsher-Smith Laboratories, Dr. Reddy's Laboratories. |
Covid-19 Impact on Testosterone Gel Market
In addition, the current Testosterone Gel Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Testosterone Gel Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Testosterone Gel Market Segment Overview
According to the Application, the market is divided into Primary hypogonadism, Hypogonadotropic hypogonadism, and Late-onset hypogonadism. Primary hypogonadism is one of the largest segments in the global Testosterone Gel market. Hypogonadism may also be known as gonad deficiency. It may be called low serum testosterone or andropause when it happens in males.
Testosterone Gel Market, By Type
· 1% Solution
· 1.62% solution
· 20 mg/1.25gm
· 25 mg/2.5 gm
· 40.5 mg/2.5gm
· 50 mg/5 g
· 1%: 1.62%
Testosterone Gel Market, By Application
· Primary hypogonadism
· Hypogonadotropic hypogonadism
· Late-onset hypogonadism
Testosterone Gel Market Regional Overview
Region-Wise, North America commanded a major share of the Testosterone Gel market, in terms of revenue. North America has a higher testosterone gel adoption rate and is expected to hold the largest market share over the projection period. This is due to factors such as the availability of well-established healthcare facilities, an increase in the frequency of chronic illnesses that can influence testosterone levels, and new product launches in the region, all of which are projected to boost the testosterone gel market's expansion. Moreover, the market in the Asia Pacific is projected to rise considerable rate in the forecast period. Because of the existence of growing economies such as India, China, and others, Asia Pacific is likely to grow rapidly. Furthermore, the growing patient population as well as a variety of other illnesses such as genetic disorders or undeveloped testicles are predicted to boost the testosterone gel market's growth.
Testosterone Gel Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Testosterone Gel Market, Key Players
· AbbVie
· Perrigo
· Teva
· Endo Pharmaceuticals
· Lupin
· Acerus Pharmaceuticals
· Upsher-Smith Laboratories
· Dr. Reddy's Laboratories
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the Testosterone Gel market?
The growth of the testosterone gel market has been propelled by the rapid development of healthcare facilities and infrastructure
Q2. Which Segments are covered in the Testosterone Gel Market report?
Type, Application, and Region. these segments are covered in the Testosterone Gel market report.
Q3. Which segment is projected to hold the largest share in the Testosterone Gel Market?
Primary hypogonadism segment is projected to hold the largest share in the Testosterone Gel Market.
Q4. Which region holds the largest share in the Testosterone Gel market?
North America held the largest share in the global Testosterone Gel market
Q5. Which are the prominent players in the Testosterone Gel Market?
AbbVie, Perrigo, Teva, Endo Pharmaceuticals, Lupin, Acerus Pharmaceuticals, Upsher-Smith Laboratories, Dr. Reddy's Laboratories. are some key players in the Testosterone Gel Market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Testosterone Gel Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. 1% Solution
- 5.2.2. 1.62% solution
- 5.2.3. 20 mg/1.25gm
- 5.2.4. 25 mg/2.5 gm
- 5.2.5. 40.5 mg/2.5gm
- 5.2.6. 50 mg/5 g
- 5.2.7. 1%: 1.62%
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Primary hypogonadism
- 5.3.2. Hypogonadotropic hypogonadism
- 5.3.3. Late-onset hypogonadism
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America Testosterone Gel Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. 1% Solution
- 6.2.2. 1.62% solution
- 6.2.3. 20 mg/1.25gm
- 6.2.4. 25 mg/2.5 gm
- 6.2.5. 40.5 mg/2.5gm
- 6.2.6. 50 mg/5 g
- 6.2.7. 1%: 1.62%
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Primary hypogonadism
- 6.3.2. Hypogonadotropic hypogonadism
- 6.3.3. Late-onset hypogonadism
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Testosterone Gel Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. 1% Solution
- 7.2.2. 1.62% solution
- 7.2.3. 20 mg/1.25gm
- 7.2.4. 25 mg/2.5 gm
- 7.2.5. 40.5 mg/2.5gm
- 7.2.6. 50 mg/5 g
- 7.2.7. 1%: 1.62%
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Primary hypogonadism
- 7.3.2. Hypogonadotropic hypogonadism
- 7.3.3. Late-onset hypogonadism
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific Testosterone Gel Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. 1% Solution
- 8.2.2. 1.62% solution
- 8.2.3. 20 mg/1.25gm
- 8.2.4. 25 mg/2.5 gm
- 8.2.5. 40.5 mg/2.5gm
- 8.2.6. 50 mg/5 g
- 8.2.7. 1%: 1.62%
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Primary hypogonadism
- 8.3.2. Hypogonadotropic hypogonadism
- 8.3.3. Late-onset hypogonadism
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Testosterone Gel Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. 1% Solution
- 9.2.2. 1.62% solution
- 9.2.3. 20 mg/1.25gm
- 9.2.4. 25 mg/2.5 gm
- 9.2.5. 40.5 mg/2.5gm
- 9.2.6. 50 mg/5 g
- 9.2.7. 1%: 1.62%
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Primary hypogonadism
- 9.3.2. Hypogonadotropic hypogonadism
- 9.3.3. Late-onset hypogonadism
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. AbbVie
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Perrigo
- 10.6. Teva
- 10.7. Endo Pharmaceuticals
- 10.8. Lupin
- 10.9. Acerus Pharmaceuticals
- 10.10. Upsher-Smith Laboratories
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
